BioSpace News Archive

Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced the publication of positive 12-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR).

Data Bridge Market Research Published Latest Global Smart Inhalers Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

BIOTRONIK’s state-of-the-art LiveSupport feature was used to remotely support two BIOMONITOR Implantable Cardiac Monitor (ICM) implants shortly after launch.

A recent report provides crucial insights along with application based and forecast information in the Global Anti Peptic Ulcer Drugs Market.

The global Bone Morphogenetic Protein (BMP) 2 market size is projected to reach US$ 675.7 million by 2030, from US$ 498.1 million in 2021, at a CAGR of 4.4% during 2022-2030.

The global Darbepoetin Alfa market size is estimated to be worth US$ 4904 million in 2021 and is forecast to a readjusted size of US$ 4010.1 million by 2028 with a CAGR of -2.8% during the forecast period 2022-2030.

The global Diabetes Drugs market size is estimated to be worth US$ 53520 million in 2021 and is forecast to a readjusted size of US$ 78200 million by 2030 with a CAGR of 5.5% during the forecast period 2022-2030.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), today announced the first patient has been dosed in the Company’s Phase 2 clinical trial of ATH434 in Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

The global Hypromellose Acetate Succinate market size is estimated to be worth US$ 42 million in 2021 and is forecast to a readjusted size of US$ 60 million by 2030 with a CAGR of 5.2% during the forecast period 2022-2030.

The global Infertility Drugs market size is projected to reach US$ 7494.8 million by 2030, from US$ 5164 million in 2021, at a CAGR of 5.4% during 2022-2030.